FDA Inspection 1036765 — TAGI Pharma, Inc.
The FDA completed an inspection of TAGI Pharma, Inc. on December 13, 2017 in South Beloit, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 13, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- South Beloit, IL (United States)